These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 580160)

  • 1. Dextran-induced lowering of prekallikrein proactivator and prekallikrein in rat plasma.
    Briseid G; Briseid K; Toverud EL; Kristoffersen J
    Acta Pharmacol Toxicol (Copenh); 1978 Feb; 42(2):93-102. PubMed ID: 580160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effects of intravenous serotonin and dextran on the levels of factor XII, prekallikrein and plasminogen in rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):314-20. PubMed ID: 6154406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma.
    Briseid K; Johansen R; Rustenberg L
    Adv Exp Med Biol; 1979; 120B():101-12. PubMed ID: 517228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prekallikrein activator and kallikrein in acetone- and kaolin-activated rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):174-80. PubMed ID: 506739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO; Briseid G
    Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextran-induced anaphylactoid reaction in man: altered reactivity of high molecular weight kininogen.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):119-26. PubMed ID: 6159774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextran-induced lowering of plasminogen proactivator and functionally active high molecular weight kininogen in the rat.
    Berstad J; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):342-9. PubMed ID: 6180597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous radiographic contrast media on the blood pressure and on factors of the contact activation system in the rat.
    Hoem NO; Briseid G; Ekelund S; Salvesen S
    Acta Pharmacol Toxicol (Copenh); 1986 Sep; 59(3):189-94. PubMed ID: 2432754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
    van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN
    Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of factor XII in rat plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Berstad J
    Acta Pharmacol Toxicol (Copenh); 1981 Jul; 49(1):43-51. PubMed ID: 6175175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein.
    Kluft C
    J Lab Clin Med; 1978 Jan; 91(1):83-95. PubMed ID: 618993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by low molecular weight dextran of the blood pressure fall and the lowering of plasminogen proactivator induced by clinical dextran in the rat.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):143-9. PubMed ID: 6189362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
    Reddigari S; Kaplan AP
    Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D; Silver LD; Hahn S; Colman RW
    Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of factor XII in plasma from rats pretreated with tranexamic acid. Inhibition of a plasmin-induced loss of the functional activity of high molecular weight kininogen.
    Briseid K; Ryssdal AB
    Acta Pharmacol Toxicol (Copenh); 1980 Sep; 47(3):161-70. PubMed ID: 6449829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotensive effect of the active fragment derived from factor XII is mediated by an activation of the plasma kallikrein-kinin system.
    Waeber G; Schapira M; Waeber B; Aubert JF; Nussberger J; Brunner HR
    Circ Shock; 1988 Dec; 26(4):375-82. PubMed ID: 2463882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.